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ABSTRACT  
Adequate nutrition is important to provide all nutrients for proper health and growth of 
young calves, especially in the presence of stressors such as cold and transport.  Serum protein 
products have been proposed to improve health and diminish effects of stress in dairy calves. The 
aim of this study was to assess a serum protein-based arrival formula (AF) and use of a serum 
protein supplement (G; Gammulin, APC Inc.) in milk replacer for neonatal male calves stressed 
by transport and cold on performance, morbidity, and mortality.  
Ninety-three male Holstein calves were stratified by arrival BW and plasma protein 
concentration, and then randomly assigned to 1 of 4 treatment groups. Treatments were 1 = 
control electrolyte, milk replacer without G (E; n = 25); 2 = AF, milk replacer without G (AF; n 
= 22); 3 = control electrolyte, milk replacer with G (EG; n = 24); and 4 = AF, milk replacer with 
G (AFG; n = 22). At arrival, calves were fed either AF or a control electrolyte solution. At the 
next feeding, all calves received either a commercial calf milk replacer (20% CP, and 20% fat; 
no G supplementation) or the same milk replacer supplemented with G. The G‐supplemented 
group received 50 g/d of G in the milk replacer during the first 14 d of feeding only. Feed offered 
and refused was recorded daily. Calf health was assessed by daily assignment of scour and 
respiratory scores. Body weight, withers height, body length, heart girth, hip height, and hip 
width were measured weekly. Blood samples were taken at d 0 (before treatments), d 2, d 7, d 
14, and d 28. Calves were weaned at d 42 and remained in the experiment until d 56.  Data were 
analyzed using the MIXED, GLIMMIX, LIFETEST, and LOGISTIC procedure of SAS (v. 9.2).  
The environmental temperature during all periods was below the lower critical 
temperature. During the first 2 wk of dietary treatment, calves fed AF had significantly longer 
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body length (P = 0.05); greater starter DM and CP intakes (P = 0.0007); superior total DM, CP, 
and ME intakes (P < 0.05); and greater cortisol concentration (P = 0.02) in blood. 
Supplementation with G resulted in greater BW (P = 0.06); greater milk replacer DM and CP 
intakes (P < 0.0001); higher total CP intake (P < 0.0001); lower mean respiratory score, less 
odds for days (P = 0.08) and number of calves (P = 0.0008) with high respiratory score; and 
greater concentrations of total protein (P = 0.04) and urea N (P = 0.01) in plasma. In addition, 
during the 8-wk experiment G supplementation resulted in improved mean fecal score (P = 0.02) 
and less antibiotic treatments per calf (P = 0.05). Mortality was greater (P = 0.02) for calves that 
did not receive G.  
Results indicated that a serum protein-supplemented arrival formula improved early 
starter and total nutrient intakes.  Addition of a serum protein product also improved early 
growth, and decreased morbidity and mortality in transported male calves. Despite the marked 
reduction in mortality of transported cold-stressed male calves fed the serum protein product, 
indicators of acute-phase response were not affected; however, protein status of calves may have 
been improved by early serum protein supplementation.   
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CHAPTER I 
INTRODUCTION 
According to the National Animal Health Monitoring System in its publication 
“Biosecurity Practices on U.S. Dairy Operations, 1991-2007” (National Animal Health 
Monitoring System, 2010), the percentage of pre-weaned heifer deaths decreased from 10.8% in 
1996 to 7.8% in 2007. Similarly, weaned heifer-calf deaths decreased from 2.8% in 2002 to 1.8% 
in 2007. Diarrhea and respiratory problems are the major causes of death for pre-weaned heifers. 
Diarrhea accounted for more than 50% of deaths since 1991, while respiratory problems 
accounted for 21 to 25% of mortality during the same period (National Animal Health 
Monitoring System, 2010). Although mortality of heifers during the pre-weaned period has 
decreased slightly, it remains a considerable problem and the risk of death is greater than in the 
post-weaned period. 
Infectious disease of the intestine is the main cause of calf diarrhea (von Buenau et al., 
2005) and is most likely to be a problem in calves < 1 mo-old. In contrast, pneumonia is the 
major cause of respiratory distress in calves (Ferrari et al., 2010) after 1 mo of age. High 
occurrence of these health problems is associated with the lack of adequate nutrition and 
management, plus the presence of environmental pathogens. For successful calf raising, 
producers must understand and manage the interactions among nutrition, disease, and 
environment (Davis and Drackley, 1998). A clear understanding of the factors associated with 
the incidence of scours and respiratory problems is fundamental to decrease morbidity and 
mortality during the pre-weaned period.  
2 
 
One of the factors associated with high morbidity and mortality during the pre-weaned 
phase is low quality and low intake of colostrum. Colostrum is a rich source of nutrients, 
containing higher amounts of solids than normal milk (Davis and Drackley, 1998). It provides 
the calf with antibodies in the form of immunoglobulins (Hammer et al., 2004). Colostrum is 
vital to the health and survival of the neonatal calf. Absorption of colostral antibodies starts to 
decrease right after birth and is completed by 36 h (Morin et al., 1997). A fundamental nutrition 
principle and management practice is to feed the newborn calf suitable amounts of high quality 
colostrum as soon as possible after birth in order to decrease disease susceptibility and neonatal 
mortality. 
Stressors such as cold weather and transport, among others, may have a negative effect 
on morbidity and mortality of the young calf. An increased risk of health problems during winter 
might be caused by higher levels of infectious agents and lower ambient temperature (Gulliksen 
et al., 2009). Scours and respiratory problems are more likely to occur during this season. On the 
other hand, transport causes physiological changes in the animal resulting in increases in plasma 
cortisol concentrations (Johnston and Buckland, 1976), immune suppression, and increases in 
heart and respiration rates (Fike and Spire, 2006). Young calves, < 1 mo-old, are more 
susceptible to transport stress; hence, morbidity and mortality can be high (Knowles, 1995). 
Adequate early nutrition is important to provide all nutrients for proper health and growth 
of young calves. However, under the presence of high environmental pathogen loads, 
unfavorable environmental conditions, stress from transport, and insufficient colostrum intake; 
proper nutrition is not enough to ensure adequate growth and health of young calves. Nutritional 
supplements and additives might help producers to improve nutrition and health status in young 
calves under adverse conditions. 
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Serum protein products have shown potential in maintaining or increasing growth and 
health while decreasing morbidity and mortality (Arthington et al., 2000; Arthington et al., 2002; 
Quigley et al., 2002). Our hypothesis in this study was that serum protein products might help 
stressed dairy calves at arrival and during the pivotal first 2 wk of life. Therefore, the objectives 
were: 1) to evaluate a serum protein-based arrival formula in the first feeding after the arrival in 
stressed (by transport and cold weather) male calves on performance, morbidity, and mortality, 
and 2) to evaluate the use of a commercial serum protein supplement (Gammulin) in milk 
replacer during the first 2 wk on performance, morbidity, and mortality of these calves. 
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CHAPTER II 
LITERATURE REVIEW  
INTRODUCTION 
Adequate nutrition is crucially important for proper health and growth of young calves as 
future replacements for the dairy enterprise. Considerable knowledge has been gained throughout 
the last decade in calf nutrition and its effects on growth and health status. However, mortality 
and morbidity remain major problems for dairy calves (National Animal Health Monitoring 
System, 2010a), especially those colostrum-deprived and stressed by transport and cold weather. 
Greater morbidity and mortality is related to poor nutrition along with unfavorable management 
and environmental conditions (Davis and Drackley, 1998). 
Raising healthy and productive replacements for the dairy enterprise is in large part a 
function of proper feeding and care of young calves. Intake of high quality and adequate amounts 
of colostrum followed by consumption of milk or milk replacer that provides adequate energy, 
protein, mineral, and vitamin contents is important to ensure adequate nutrition and high survival 
in newborn calves (National Research Council, 2001). Offering a palatable calf starter, as soon 
as possible after birth, helps to stimulate rumen development and may allow early weaning (Hill 
et al., 2005).  
Nutrition and management are not the only factors affecting calf performance; 
environmental conditions and other stressors also have a significant impact. Presence of stressors 
along with unfavorable conditions increases risk and susceptibility of calves to high morbidity 
and mortality. Under such circumstances adequate nutrition is compromised and proper calf 
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performance may not be achieved. Nutritional supplements may help to overcome negative 
effects of adverse conditions and improve nutrition in such circumstances. Recently, serum 
protein and plasma protein-based products have shown potential to improve health and nutrition 
in young pigs and calves.  
 
Calf’s Digestive System Development 
Although the digestive system of the calf starts to develop early in the embryonic stage it 
is immature at birth (Davis and Drackley, 1998). At this time, the stomach contains the same 
four compartments found in adult ruminants. However, the reticulum, rumen, and omasum are 
not active and fully developed. From birth to about 2 wk of age, the calf is basically monogastric, 
because the abomasum is the only stomach compartment actively involved in digestion 
(Drackley, 2008). During this time, nutrients are acquired mainly from milk or milk replacer. 
Development of the other compartments occurs later and is determined by the diet consumed. As 
the calf begins to eat dry feeds, particularly grains containing readily fermentable carbohydrates, 
the other stomach compartments start to develop in size and function until the calf becomes a 
functional ruminant.  
 While the digestive system is developing in the process of becoming a true ruminant, , 
the calf goes through three phases: pre-ruminant, transition, and ruminant (National Research 
Council, 2001). In the pre-ruminant phase the digestive tract is more similar to humans than 
cows. During this time, in absence of a functional reticulo-rumen the calf relies on digestive 
enzymes to break down nutrients present in milk or milk replacer. Milk replacer passes directly 
to the abomasum through the reticular groove, which consists of muscular folds that make up a 
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duct that prevents liquid feed from entering into the undeveloped reticulo-rumen (Davis and 
Drackley, 1998). Once in the abomasum, digestive enzymes released primarily from the 
pancreas, abomasum, and small intestine carry out the digestion process. Chymosin and pepsin 
activated by hydrochloric acid act on casein of the milk in the abomasum (Guilloteau and 
Zabielski, 2005). A curd that binds casein and fat is formed and slowly digested in the 
abomasum. The fraction of milk that does not form a curd is called whey, which goes directly 
into the small intestine for digestion and end-product absorption (Drackley, 2008).  
During the pre-ruminant stage, digestive enzymes are unable to digest complex feeds 
other than milk (Guilloteau and Zabielski, 2005).Iif good quality starter is offered as early as 
possible, by 3 wk of age the digestive enzymes of the calf become more active. As the calf’s 
ability to eat and digest starch increases it moves to the transition phase (National Research 
Council, 2001). During this phase the calf is generally fed milk replacer and grain with or 
without forage. Greater intake of starter over forage during the transition period allows better 
development in function, but perhaps not size, of the rumen (Heinrichs and Lesmeister, 2005). 
High quality starter, high in fiber and readily fermentable carbohydrates, allows development of 
rumen papillae and increases the rumen microbial population (Drackley, 2008). The developing 
rumen microbial population ferments carbohydrates in starter leading to greater production of 
volatile fatty acids (VFA), mainly propionate and butyrate. Volatile fatty acids, especially 
butyrate and to a lesser extent propionate, stimulate rumen papillae development and 
functionality (Davis and Drackley, 1998). As the rumen papillae become functional their ability 
to absorb VFA increases, which drives changes in rumen environment. Rumen pH begins to 
increase and with it the cellulolytic bacteria population increases; however, physical size of the 
rumen limits forage intake at this time. Despite capacity limitation in the rumen, if good quality 
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starter is offered and intake is acceptable, nutrient requirements for maintenance and growth can 
be satisfied.  
Development of a functional rumen as soon as possible, from an efficiency and economic 
standpoint, is crucially important in heifer raising programs. Successful replacement programs 
removed calves from liquid diets to lower feed cost, reducing the risk of digestive upsets while 
developing a functional rumen (Hutjens, 2003). In this way, when the calf is eating enough 
starter to support its growth, 0.9 kg or more calf starter (Hutjens, 2003), it can be weaned and 
considered a true ruminant. 
 
Calf’s Nutritional Requirements 
As a future replacement the newborn calf must be fed highly digestible feeds containing 
appropriate levels of high-quality nutrients. Like other animals, the young calf has requirements 
for energy, protein, vitamins, and minerals for maintenance and to support adequate growth and 
health.  
Energy. Requirements for energy in young calves are stated depending on the feeding 
system and/or digestive system development phase: calves fed only milk or milk replacer, 
milk/milk replacer and starter feed, and weaned calves (National Research Council, 2001). 
Energy requirement is expressed in units of metabolizable energy (ME), which is total energy 
intake minus energy loss in feces, urine, and gases (Drackley, 2008).  In addition, energy 
requirements for growing calves are partitioned into ME for maintenance and ME for growth. 
Energy required for maintenance refers to the amount of energy necessary to support essential 
body functions (body temperature regulation, essential metabolic processes, and physical 
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activity) (National Research Council, 2001). Energy required for growth refers to energy needed 
for deposition of new skeletal and muscle tissue (National Research Council, 2001). The ME 
requirements would vary depending on BW, rates of gain, environmental conditions, health 
status, and stress factors. The National Research Council establishes energy requirements for 
maintenance for a 45-kg calf fed milk/milk replacer and starter, under thermoneutral conditions, 
to be 1.81 Mcal of ME/d. The thermoneutral zone would vary depending on many factors: calf’s 
age, feed intake, and amount of subcutaneous fat and hair coat (National Research Council, 
2001). From birth to 3 wk of age the thermoneutral zone for calves is defined as 15 to 25 °C 
(National Animal Health Monitoring System, 2010a). As the calf gets older the thermoneutral 
zone range increases. When the ambient temperature drops below the lower critical temperature 
(15°C) ME requirements for maintenance are increased.  The NRC states that ME for 
maintenance increases approximately 14% for every 5 °C that ambient temperature decreases 
below the lower critical temperature (National Research Council, 2001).   
Protein. Requirement for protein is expressed in terms of apparently digestible protein 
(ADP) (National Research Council, 2001). The requirement for ADP is calculated from the 
formula 𝐴𝐷𝑃 (𝑔/𝑑) = 6.25 [1/𝐵𝑉  (𝐸 + 𝐺 + 𝑀 ∗ 𝐷) −𝑀 ∗ 𝐷] where 6.25 is the factor to 
convert N to protein; BV = biological value of proteins; E = endogenous N excretion (g/d); G = 
the N (g/d) stored in liveweight gain; M = metabolic fecal N (g/kg); and D = DM intake (kg/d) 
(Davis and Drackley, 1998).  
Protein requirements vary with the rate of BW gain expected; greater average daily gains 
(ADG) will require greater amounts of protein intake. Similar to energy, requirement for protein 
is partitioned into components of maintenance and gain. Requirement for maintenance is 
assessed from metabolic fecal N and endogenous urinary N losses. Metabolic fecal N is the non- 
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dietary N found in feces, which originates from gut tissue, bacterial debris, and digestive 
secretions. Endogenous urinary N, expressed on the basis of metabolic body size (kg0.75), 
originates from tissue metabolism (Davis and Drackley, 1998). For gain, the NRC assumes a 
constant of 30 g of N per kg of BW gain, which is equivalent to 187.5 g of protein per kg of BW 
gain (National Research Council, 2001).  
An important concept in the formula for requirement of ADP is the biological value (BV) 
of proteins. According to (National Research Council, 2001), BV refers to how adequately 
balanced is the amino acid profile of the diet being fed, and assumes that energy intake is enough 
to support protein synthesis. This relates to the importance of energy – protein interrelationships 
in the diet. Feeding higher amounts of protein without enough energy will result in waste of 
protein and excretion of N. Conversely, higher energy intake with inadequate intake of protein 
will result in fat, rather than lean tissue, deposition (Drackley, 2008). The BV for milk is 
considered to be 80 to 90% (Davis and Drackley, 1998) while BV for starter is assumed to be 
70% (National Research Council, 2001).  
 Protein content in feeds is expressed as crude protein (CP). Requirements also are 
expressed in terms of CP. Conversion of ADP to CP is a function of digestibility and BV of 
feeds. For milk proteins conversion of CP to ADP is assumed to be 93% while for starter and 
grower feeds the conversion of CP to ADP is 75% (National Research Council, 2001).  
Vitamins and Minerals.  Requirements for vitamins and minerals in young calves are not 
as well defined as they are for pigs, chickens, and older cattle (Drackley, 2008). Calves have 
requirements for many of the same minerals and vitamins as other animals. Required vitamins 
are: vitamin K, water-soluble B vitamins (thiamine, riboflavin, niacin, choline, biotin, 
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pyridoxine, folic acid, B12, and pantothenic acid), and fat-soluble vitamins (A, D, and E) (Davis 
and Drackley, 1998). Most of the minerals and vitamins are found in colostrum, fermented 
colostrum, milk/milk replacers, and starter grain fed to calves during younger age. Once the 
rumen becomes functional microorganisms in the rumen produce some of the B-vitamins and 
supplementation may not be needed. Vitamin C, synthesized in the calf’s tissues, is not required 
in the diet. 
Water. Although not always seen as important water is an essential and critically 
important nutrient. Water is important to carry out metabolic process and is deposited in greatest 
amount in calf tissue during growth (Drackley, 2008). Fresh and clean water should be available 
at all times, especially in growing calves. Water and starter intake are highly related; as starter 
intake increases water intake increases as well (Davis and Drackley, 1998). Scouring calves lose 
considerable amount of water and electrolytes resulting in dehydration and electrolyte imbalance 
(National Research Council, 2001). Resent research demonstrated that calves that were offered 
warm water had greater intake than calves offered cold water (Huuskonen et al., 2011). This may 
be important to encourage water intake, particularly in dehydrated calves, in winter where water 
intake could be low. 
 
Calf’s Feeds 
Colostrum. The first milk produced after a normal dry period contains antibodies in the 
form of immunoglobulins (Ig), which are critical in providing the calf with passive immunity 
from infectious diseases (Godden, 2008). Colostrum provides essential nutrients, contains twice 
as much DM, three times as many minerals, and five times as much protein as whole milk (Davis 
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and Drackley, 1998). It is also higher in energy and vitamins (National Research Council, 2001). 
The high content of fat and vitamins A, D, and E in colostrum is especially important because 
the newborn calf has low reserves of these nutrients. In addition, the relatively low lactose 
content of true colostrum may reduce the incidence of diarrhea. 
Antibodies in bovines cannot cross the placental barrier from the cow to the fetus 
(Hutjens, 2003) . Different from many other species, calves are born with no disease protection. 
They receive Ig through passive transfer by consuming adequate amounts of colostrum within 
the first few hours after birth (Davis and Drackley, 1998). Absorption of antibodies directly from 
the gut into the bloodstream starts to decrease right after birth and ceases by 36 h (Morin et al., 
1997). Consequently, timing of colostrum feeding is critically important because of the limited 
time to absorb Ig and the potential for pathogenic bacterial colonization of the intestine (Godden 
et al., 2009). The primary colostrum antibodies are immunoglobulins G (IgG), A (IgA), and M 
(IgM). The IgG fraction constitutes 80 to 85% of all Ig in colostrum and provides immunity 
against a wide variety of systemic infections and disease. The IgM makes up 5 to 12%, is an 
important contributor to early immunity especially to enteric pathogens, and is most important in 
prevention of septicemia.  Secretory production of IgA in bovine is less than in many other 
species, constituting 8 to 10% of the immunoglobulins. In the calf, many of the functions of IgA 
in other species are assumed by IgM and IgG (Davis and Drackley, 2008; Godden, 2008). 
Important factors affecting calf morbidity and mortality during the pre-weaning period 
are the quality, quantity, and timing of colostrum fed (Gulliksen et al., 2009c). Colostrum quality 
is a function of Ig concentration and the presence or absence of bacteria. Quality depends on 
several factors, including immune status of the cow, age of the cow, volume of colostrum 
produced, cow nutrition, breed, and season of the year (Godden, 2008). An easy and practical 
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way to estimate quality of colostrum in the field is through a colostrometer. The colostrometer, a 
hydrometer, estimates IgG concentration by measuring specific gravity of colostrum. Colored 
areas on the scale indicate whether the colostrum is superior, acceptable, or unacceptable for 
feeding newborn calves (Hutjens, 2003). Good quality colostrum contains at least 50 g/L of IgG 
(Davis and Drackley, 1998) 
Another important factor when feeding colostrum is quantity. Calves should receive 2 to 
3 L of undiluted colostrum as soon as possible after birth, and another 2 to 3 L within 8 h (Jaster, 
2005). If the second feeding is not possible 4 L of colostrum should be fed in a single feeding. 
Newborn calves generally will not drink a large amount of colostrum by themselves at one time; 
in this case an esophageal feeder may be used to feed all or part of the colostrum.  
Colostrum supplements and colostrum replacers are another option when high quality 
colostrum is not available. These products can be added to marginal colostrum when no other 
source of colostrum is available. Several studies indicate that calves fed colostrum supplements 
and colostrum replacers have performed as well as calves fed maternal colostrum with no 
differences in IgG concentrations, incidence of scours, or growth rates (Quigley III et al., 1998; 
Jones et al., 2004). Colostrum replacers have more Ig than colostrum supplement products and 
provide more antibodies than poor or moderate quality colostrum (Morin et al., 1997). 
Liquid Feed. Consumption of adequate amounts of high quality colostrum is the first step 
to ensure calf survival. Next, the calf needs to be fed with liquid feed containing adequate 
amounts of highly digestible nutrients. There are several liquid feed options available to feed the 
young calf. These include milk replacers, waste milk, fresh or fermented colostrum, or whole 
milk (Drackley, 2008). Any of these is excellent feed when available and if it fits into the calf-
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raising program. Research indicates that a variety of liquid feeds fed at correct dilution rates can 
achieve satisfactory results. 
Generally, milk replacers are fed on most farms in United States. Nutrient levels, 
composition, and quality vary considerably among milk replacers. Composition and quality of 
milk replacer influence growth, health, and overall performance of calves (National Research 
Council, 2001). Milk replacers generally contain 18 to 28% CP and 15 to 22% crude fat. In 
addition, they should contain and be well-balanced for major minerals (including calcium, 
phosphorus, and magnesium), trace elements, and vitamins. In milk replacers, milk proteins are 
typically more digestible and contain a favorable profile of amino acids (Tanan, 2005). However, 
they are the most expensive source of protein. In an effort to reduce cost, extensive research has 
been conducted in search for alternative protein sources.  
Plant proteins have been extensively evaluated. Plant protein sources often contain more 
crude protein than milk proteins; however, protein quality or amino acid balance is slightly 
inferior (Drackley, 2008). Soy proteins have been evaluated and can provide an economic 
alternative to milk proteins. These vegetable proteins can be substituted for a portion of the milk 
proteins in milk replacers, providing acceptable calf growth and performance. Some vegetable 
proteins contain anti-nutritional compounds that cause allergic reactions, poor digestion, or 
diarrhea (Drackley, 2005; Tanan, 2005). 
Another protein source for calf milk replacer that has received attention by the scientific 
community is protein from animal origin (Drackley, 2005; Drackley, 2008). Egg proteins have 
been incorporated into commercial milk replacers with variable results. Calves fed milk replacers 
containing animal plasma proteins also have shown to have similar or improved performance 
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than calves fed milk proteins (Quigley and Bernard, 1996; Quigley et al., 2000; Quigley and 
Wolfe, 2003). 
Carbohydrates and fat are important as a source of energy in milk replacers. During the 
pre-ruminant phase, the calf’s digestive system is not well-developed (Guilloteau and Zabielski, 
2005). At this time, the major sources of energy are lactose (milk sugar) and highly digestible 
fat. Lactose is a carbohydrate and is the other major energy source in milk replacers (Davis and 
Drackley, 1998). A typical milk replacer formulation contains about 40 to 45% lactose. Fats and 
oils provide a concentrated energy source for animal feeds. Fat levels in milk replacers typically 
range from 10 to 24%, with 15 to 20% being the most common. Calves can digest saturated fats 
including milk fat, coconut oil, lard, and tallow; however, they have limited ability digesting 
unsaturated fats such as corn and soybean oils (Drackley, 2008).  Higher fat milk replacers are 
often selected for cold climates while low-fat formulas are more often used in hot climates and in 
formulations designed for intensive milk replacer feeding programs (Drackley, 2008). 
Dry Feed. The pre-weaned calf requires both liquid and dry feeds. Conventional feeding 
programs typically rely on dry feed intake to meet large portions of the calf’s requirement. Early 
intake of dry feed in young calves is important to stimulate development of the reticulo-rumen 
(Hill et al., 2005). Developing of the rumen as a fermentation chamber in the young calf is 
crucially important from an efficiency and economy standpoint as it decreases feed costs, lessens 
labor needs, and can overcome the calf’s stress associated with the transition from pre-weaned to 
weaned stage (Hutjens, 2003). 
Rumen development in the young calf is separated into two components: physical size 
(volume) and the development of rumen papillae (functionality) (Heinrichs and Lesmeister, 
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2005). When dry feed is offered beginning in the first week of age, the calf increases intake as it 
ages, which increases the size of the rumen (Drackley, 2008). The development of the rumen 
papillae (elongation and absorptive function) is a function of the diet ingested. Limitation in size 
of the rumen, fewer cellulolytic bacteria, and low digestibility of forages makes starters a better 
option to feed calves at younger age. In addition, extensive research has demonstrated that starter 
is more effective than forage in developing the absorptive epithelium of the rumen. Fermentation 
of starter in the rumen leads to high production of VFA, especially propionate and butyrate 
(National Research Council, 2001). Butyrate and to a lesser extent propionate stimulate growth 
and differentiation of rumen papillae (Heinrichs and Lesmeister, 2005). High quality starter, high 
in fiber and readily fermentable carbohydrates, should be offered from a very early age 
(Drackley, 2008) 
There are many types of calf starters available on the market. Starters are a good source 
of energy, protein, minerals, and vitamins, and may include antibiotics that improve efficiency of 
nutrient use and offer protection against pathogens. In general, calf starter should be palatable 
and provide nutrients required for rumen development and adequate calf growth (Drackley, 
2008).  Small amounts of forage are also important to promote muscular growth and maintain 
health of the rumen epithelium (Hill et al., 2005). At an early age rumen pH is low and the 
population of cellulolytic bacteria is not sufficiently high to digest forages. As starter intake 
increases rumen pH rises; this favors development of the population of cellulolytic bacteria. 
Despite the increase in cellulolytic bacteria, digestibility of forages by the increased bacteria 
population is still limited. When the calf is consuming around 2.0 kg of starter, generally after 
weaning, good quality forage (hay or haylage) can be offered (Hutjens, 2003). 
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Calf’s Health and Stressors 
Health is as important as nutrition to ensure proper growth and high survival of the young 
calf. Considerable knowledge has been gained during the last decade in calf nutrition and its 
impact on health status. Morbidity and mortality during the pre-weaned period still remain high 
in some dairy farms in United States (National Animal Health Monitoring System, 2010a). 
According to (National Animal Health Monitoring System, 2010a) diarrhea accounted for more 
than 50% of pre-weaned heifer deaths while respiratory problems accounted for 25% during the 
same period.  
Causes of diarrhea in pre-weaned calves can be grouped in three areas: mechanical, 
nutritional, and environmental causes. Mechanical causes include, for example, overfeeding and 
drastic changes in liquid feed source. Nutritional causes are related with feeding milk replacers 
of poor quality or containing poorly digestible ingredients; inclusion of soy flour in milk 
replacers is a typical example. Mechanical and nutritional causes are not considered a disease 
problem and will not respond to antibiotic treatments. Environmental causes are associated with 
presence of pathogens causing enteric disease. Bacteria such as Escherichia coli, Salmonella sp, 
and Clostridium perfringens; protozoa such as Coccidia and Cryptosporidia; and rota- and 
coronavirus are common pathogens causing calf scours (Gulliksen et al., 2009a). Respiratory 
problems, the second leading cause of death in pre-weaned heifer and principal cause in weaned 
heifer (National Animal Health Monitoring System, 2010a), are associated with housing, season, 
and diarrhea incidence (Gulliksen et al., 2009b).  
Clearly, enteric disease and respiratory issues are the major health problems associated 
with morbidity and mortality during the pre-weaned period. Presence of pathogens along with 
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poor nutrition and management increase stress on calves, resulting in greater incidence of disease 
problems (Davis and Drackley, 1998). The principal nutritional and management factor 
associated with high morbidity and mortality in pre-weaned calves is colostrum intake. 
Colostrum-deprived calves present weak immunity and greater susceptibility to diseases. Higher 
levels of infectious agents, lower ambient temperature, and higher humidity of inside air might 
increase susceptibility to disease in winter (Gulliksen et al., 2009a). Although reasons were not 
determined, research done by Olson et al. (1980b) demonstrated that cold stress decreased rate of 
absorption of colostral immunoglobulins, compromising immunity of calves born in winter. 
Several research reports point out that stressors negatively affect the immune response of 
pre-weaned calves. As measured by increases in plasma cortisol transportation was found to be 
the greatest stressor in male Holstein calves (Johnston and Buckland, 1976) , compared to water 
withdrawal, castration, and dehorning. According to Mackenzie et al. (1997), stressors such as 
transportation, weaning, and poor housing affected the immune response of pre-weaned calves 
and the effects persisted for several weeks. Cold, another important stressor in young calves, 
affected the clinical condition of newborn calves and represented the major contributor of 
disease and death of young calves in cold climate areas (Olson et al., 1980a). Also, Kelley et al. 
(1982) reported that chronic heat and cold caused greater mortality and affected immune 
response by altering both antibody- and cell-mediated immunity in young calves.  
Calves may react to stressors either by behavioral or physiological responses, but most 
often present a combination of both. Physiological reactions to stress have been investigated 
more than behavioral responses. Physiological changes result in activation of the hypothalamic- 
pituitary-adrenal axis, resulting in increases in cortisol concentrations, immune suppression, and 
increased heart and respiration rates (Fike and Spire, 2006). Changes in hormones such as 
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cortisol, heart and respiration rates, and fluctuations in white blood cell counts have been utilized 
to quantify stress responses. In the short term, stressors can increase heart rate, increase 
respiration rate, and decrease feed intake. On the other hand, in the long term stressors can 
influence essential hormones involved in growth, energy metabolism, immune system, and 
reproduction (Knowles, 1995). 
A series of reactions known as the acute-phase response begins in response to infection or 
physical trauma. The objective of these reactions is to prevent ongoing tissue damage, isolate and 
destroy the infective organism, and activate the repair processes necessary to restore normal 
functions (Baumann and Gauldie, 1994; Ballou et al., 2011). Acute-phase response is 
characterized by increases in white blood cells, fever, and changes in the plasma concentrations 
of various acute-phase proteins (Kushner, 1993; Ballou et al., 2011). Acute-phase proteins have 
been defined as any protein whose plasma concentrations increases (positive acute-phase 
proteins) or decreases (negative acute-phase proteins) in response to an inflammatory disorder. 
Positive acute-phase proteins include fibrinogen, serum amyloid A, C-reactive protein, and 
haptoglobin, while negative acute-phase proteins include albumin, transferrin, insulin, and 
insulin-like growth factor I (Kushner, 1982). 
Extensive research reports that products containing coccidiostats, probiotics, or plasma 
proteins may improve performance and health of the young calf (Morrill et al., 1995; Quigley  et 
al., 1997; Quigley et al., 2002). According to Nonnecke et al., 2009) pre-ruminant calves 
provided with adequate nutrition exhibit a remarkable degree of adaptability to sustained 
moderate cold. However, extreme environmental conditions along with poor management may 
impair nutrition enough to reduce calf performance. In an effort to overcome negative effects of 
adverse conditions and poor management, researchers and industry are constantly looking for 
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possible alternatives. Recently, research in pigs and also in calves (Arthington et al., 2000b; 
Quigley et al., 2002) suggested that serum protein products may improve health and decrease 
morbidity and mortality (Quigley and Wolfe, 2003), while maintaining or increasing growth. 
These results are promising; however, to validate the effectiveness of serum protein products it is 
necessary to evaluate them under unfavorable conditions.  
 
Animal Protein Products (Serum and Plasma Protein) 
Commercial calf milk replacer formulations are widely used in the US dairy industry to 
provide nutrients to calves prior to weaning (Quigley and Bernard, 1996). According to the 
National Animal Health Monitoring System (2010b), 57.5% of the dairy operations fed 
medicated milk replacer while 12.7% fed non-medicated milk replacer. These formulations have 
traditionally contained ingredients based on milk, including whey, dried skim milk, and lactose. 
Most protein in milk replacer is provided from these ingredients (Quigley and Bernard, 1996). 
The value of milk as a human food makes milk proteins the most expensive in milk replacer 
formulas (Morrill et al., 1995). As the use of milk components in human food increases the 
availability of milk proteins may decline in the future (Quigley et al., 2000). Alternative sources 
of protein in milk replacer have attracted intense interest, as they may decrease cost and improve 
profitability of the heifer rearing program. Many alternative proteins have been evaluated in milk 
replacer formulations, including soy protein (Dawson et al., 1988; Lalles et al., 1995; 
Kanjanapruthipong, 1998), wheat protein (Terui et al., 1996), egg protein (Touchette et al., 
2003), and fish protein ( Huber, 1975; Opstvedt et al., 1978; Jenkins et al., 1982). Many of these 
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alternative protein sources have reduced calf performance (Huber and Slade, 1967; Colvin and 
Ramsey, 1968; Seegraber and Morrill, 1986; Quigley et al., 2002; Drackley et al., 2006). 
More recently, blood proteins from porcine or bovine origin have shown potential as 
alternative sources of protein in milk replacer (Morrill et al., 1995). Blood consists of two 
components: a fluid portion called plasma, and formed elements, which include cells 
(erythrocytes or red blood cells, and leukocytes or white blood cells) and cell fragments called 
platelets. Plasma is an aqueous solution in which a great variety of proteins, small nutrients (such 
as glucose, lipids, and amino acids), metabolic waste products (such as urea and lactic acid), 
gases (oxygen, carbon dioxide, nitrogen, and others), and electrolytes (such as sodium, 
potassium, and chloride) are dissolved. Plasma proteins are categorized in three main groups: 
albumins (the most abundant plasma proteins), globulins (transport lipids, hormones, and other 
substances in the blood; important and defending the body against foreign substances), and 
fibrinogen (key substance in the formation of blood clots) (Germann and Stanfiled, 2002). 
Erythrocytes (red blood cells) are the most abundant cells in the blood, in which the major 
function is the transport of oxygen and carbon dioxide in blood. Leukocytes (white blood cells) 
are far less numerous than red blood cells in blood. White cells assist in defending the body 
against invading microorganisms and other foreign materials (Tortora and Derrickson, 2009). 
Blood is collected at slaughter plants from animals determined to be fit for slaughter by 
veterinary inspection.  The blood is transferred to stainless steel tanks and treated with an 
anticoagulant, then transported to a processing plant. The plasma is then separated from blood 
cells by centrifugation and chilling to 4 to 5°C. In the manufacturing of blood meal, blood has 
traditionally been collected and heated to high temperature, which destroys the functional 
components of the proteins. Conversely, spray-dried plasma proteins are processed to preserve 
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the functional characteristics of the proteins, including biologically active peptides such as 
albumin and IgG (Quigley and Wolfe, 2003).  
 Extensive research has demonstrated that calves fed milk replacer containing animal 
plasma have performed similar to or better than calves fed proteins derived from milk. Body 
weight gain and starter consumption were greater in calves fed milk replacer containing 25% of 
protein from porcine or bovine origin compared to calves fed milk replacer containing all milk 
protein or all milk protein plus probiotic (Morrill et al., 1995). Plasma proteins fed at 25% of CP 
in milk replacer also supported intake and rates of BW gain similar to milk replacer containing 
milk proteins (Quigley and Bernard, 1996). In another experiment Quigley and Wolfe (2003) 
compared milk replacer formulated with whey protein concentrate as the primary source of 
protein with milk replacer containing whey protein concentrate plus 5% (of total DM) spray-
dried bovine or porcine plasma. It was concluded that dietary plasma either from bovine or 
porcine origin is a potential source of biologically active proteins, including immunoglobulins, 
and reduced morbidity and mortality when included in commercial milk replacer.  
 In pigs, the use of animal plasma has given favorable results. Faster growth and greater 
feed intake were observed by Pierce et al., (2005) when early weaned pigs were fed spray-dried 
porcine or bovine plasma. According to Pierce et al. (2005), the IgG fraction of plasma is the 
component that is responsible for enhanced growth rate and feed intake in early weaned pigs. In 
an effort to replace dried skim milk or dried whey in diets of starting pigs, Hansen et al. (1993) 
evaluated spray-dried porcine plasma, spray-dried porcine blood, spray-dried bovine plasma, and 
spray-dried extracted meat protein.  Porcine plasma protein supplementation was superior to 
skim milk, and positively influenced growth performance of starting pigs (Hansen et al., 1993).   
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Bovine serum, which is plasma from which the coagulation factor fibrinogen has been 
removed (Germann and Stanfiled, 2002), also has been used in nutrition of young calves. Dried 
bovine serum was effectively used as a supplement for marginal or low quality colostrum to 
improve passive transfer of IgG in newborn calves (Arthington et al., 2000a; Arthington et al., 
2000b). Milk replacer containing spray-dried animal plasma with the addition of spray-dried 
serum was evaluated by (Quigley et al. (2002) in a 56-d trial. Results indicated that calves fed 
additives containing bovine serum or milk replacer containing spray-dried plasma had lower 
mortality and improved indices of enteric health (Quigley et al., 2002). No differences in calf 
performance were reported by Jones et al. (2004) when feeding maternal colostrum and replacer 
colostrum derived from bovine serum with milk replacer with or without animal plasma. It was 
concluded by Jones et al. (2004) that colostrum replacement from bovine serum offered equal 
protection as maternal colostrum and that animal plasma is an acceptable replacement for up to 
20% of milk proteins in milk replacer. 
Spray-dried red blood cells are a co-product of plasma production (Duarte et al., 1999) 
and have shown potential as an alternative protein in milk replacer. Quigley et al. (2000) 
concluded that performance was similar among calves fed milk replacer containing different 
amounts of CP as spray-dried hydrolyzed red blood cells and indicated that spray-dried 
hydrolyzed red blood cells can replace up to 43% of CP from whey proteins without detrimental 
effects on calf performance. In pigs, DeRouchey et al. (2002) compared spray-dried blood meal 
and blood cells with a control diet without added blood products; they concluded that improved 
BW gain and feed efficiency were observed in diets containing blood product compared to those 
fed the control diet without added blood products. 
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The mechanisms through which dietary plasma improves animal performance are not 
completely clear. The complex mixture of physiological components in dietary plasma including 
immunoglobulins (Arthington et al., 2000b), antibodies, growth factors (Hansen et al., 1993), 
glycoproteins, and modulators of the immune system appears to increase disease resistance 
(Pettigrew et al., 2006). In addition, plasma proteins are highly digestible and soluble, and 
possess a reasonable amino acid profile with the exception of very low isoleucine and 
methionine (Tybor et al., 1975; Penteado et al., 1979; Drackley, 2008). Properties and 
components of plasma may make it a valuable source of dietary components for young calves 
especially during periods of stress.  
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 CHAPTER III 
EVALUATION OF SERUM PROTEIN-BASED ARRIVAL 
FORMULA AND SERUM PROTEIN (GAMMULIN) IN 
STRESSED (TRANSPORT AND COLD) MALE DAIRY CALVES 
ON PERFORMANCE, MORBIDITY, AND MORTALITY 
 
INTRODUCTION  
The most challenging period for the young calf is from birth until weaning; during this 
time the calf experiences remarkable physiological, metabolic, and environmental changes 
(Davis and Drackley, 1998). Despite the advances in calf nutrition and health, higher morbidity 
and mortality occur during this time (Quigley et al., 2005; National Animal Health Monitoring 
System, 2010). For the dairy enterprise, decreased morbidity and mortality is important because 
of the economic losses associated with treating illnesses, decreased calf performance, and death. 
Factors associated with poor performance are morbidity, poor management during the pre-
weaned period, nutrition, and the presence of stressors such as cold weather and transport (Wells 
et al., 1996; Svensson et al., 2006b; Gulliksen et al., 2009; Vasseur et al., 2010).  
 Young calves represent future replacements for the dairy enterprise. Successful heifer 
raising programs result in healthy calves of adequate frame size and with good rumen 
development. Success in calf rearing is a function of excellent nutrition and management 
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practices that start as soon as the calf is born. Adequate colostrum intake and provision of a dry, 
comfortable, and clean environment to minimize exposure to pathogens is the first step to 
provide better adaptation of the newborn calf to the new environment (Quigley et al., 1995; 
Godden, 2008). Colostrum-deprived calves exposed to unfavorable conditions after birth exhibit 
greater risk for high morbidity and mortality (Quigley et al., 2005; Godden, 2008; Gulliksen et 
al., 2009). Subsequent nutrition is crucially important to provide all the nutrients for proper 
growth and health. However, adequate nutrition is not enough to ensure proper survival, growth, 
and health of the young calf in circumstances where the calf is immunologically disadvantaged, 
facing unfavorable environmental conditions, or subjected to other stressors. Transport (Johnston 
and Buckland, 1976; Odore et al., 2004) and cold weather represent stressors for the young calf, 
affecting its immune system (Odore et al., 2004; Fike and Spire, 2006) and increasing the 
susceptibility to enteric and respiratory problems (Fike and Spire, 2006; Svensson et al., 2006a), 
which are the principal causes of high morbidity and mortality during the pre-weaned period 
(National Animal Health Monitoring System, 2010). 
 In an effort to improve nutrition and diminish the negative effects of poor management 
and unfavorable conditions, several dietary supplements and additives have been proposed. 
Extensive research reports that products containing coccidiostats, prebiotics, probiotics, or 
plasma proteins may improve performance and health of the young calf. Research in pigs and 
also in calves (Arthington et al., 2000b; Quigley III et al., 2002) suggested that serum protein 
products improve health and decrease morbidity and mortality (Quigley and Wolfe, 2003), while 
maintaining or increasing growth. Based on these data, our prediction was that serum protein 
products would improve performance, morbidity, and mortality of dairy calves subjected to the 
stressors of winter cold weather and transport, especially during their first 2 wk of life. 
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MATERIALS AND METHODS 
Animal Management 
 All procedures were approved by the University of Illinois Institutional Animal Care and 
Use Committee (protocol number 06132). Ninety-three male Holstein calves, < 1-wk old, were 
purchased from dairy farms in New York by a buyer in three blocks of 30 to 33 and shipped to 
the University of Illinois Nutrition Field Laboratory. Calves were transported in a livestock 
trailer and subjected to a ~14-h trip. The first group was acquired in February 2009 (32 calves), 
the second group in November 2009 (31 calves), and the third in January 2010 (30 calves).  
 Each group of calves was evaluated by the veterinary staff upon arrival. The evaluation 
included heart and lung auscultation, hydration status, alertness, mobility, navel status, and body 
temperature. Each calf received an ear tag in the left ear for identification purposes. Calves were 
subjected to the normal arrival and post‐arrival processing scheme, which consisted of an 
intramuscular injection of  1.0 mL of Mu-Se (Shering-Plough Animal Health Corp., Union, NJ), 
an intranasal vaccination with  TVS-2® (Pfizer, Inc., New York, NY), and a prophylactic 
subcutaneous injection of 1.5 mL of Excede (Pfizer, Inc., New York, NY). Ear notches were 
taken from each calf, placed in formalin, and analyzed for persistently infected bovine viral 
diarrhea (PI-BVD) status. Navels were coated with 7% tincture of iodine solution (First Priority, 
Inc., Elgin, IL) and rectal temperatures were recorded. A blood sample was obtained by jugular 
venipuncture and plasma protein was determined by refractometry; calves then were weighed.   
 Calves were stratified by arrival BW and plasma protein, blocked, and randomly assigned 
within blocks to one of four treatments. Treatments were assigned in a 2 × 2 factorial 
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arrangement of arrival formula (AF) and Gammulin (G) supplementation as follows: 1) control 
electrolyte, milk replacer without G (E); 2) AF, milk replacer without G (AF); 3) control 
electrolyte, milk replacer with G (EG); and 4) AF, milk replacer with G (AFG). 
Housing  
 Calves were housed in individual hutches (Calf-tel, Hampel Corp., Germanton, WI) 
bedded deeply with straw over crushed rock covered with landscape cloth. Straw was added to 
each hutch daily. Calves remained in hutches from arrival until d 56 when they were sold.  
Feeds and Feeding Program 
The AF (APC, Inc., Ankeny, IA) nutritional supplement was administrated via nipple 
feeder or esophageal feeder upon arrival, and was prepared by mixing 250 g of AF in 2 L of 
warm (40 °C) water. The ingredient composition of AF is shown in Table 3.3 and contained 
spray-dried bovine serum in addition to milk products (dried whey and dried whey protein 
concentrate), minerals, electrolytes, and vitamins.   Administration of AF was compared with 
administration of a commercial electrolyte solution (Land O’Lakes® electrolyte system; Land 
O’Lakes Animal Milk Products Co., Arden Hills, MN), which was prepared by mixing 77 g in 2 
L of warm (45 °C) water.  
Commercial non-medicated milk replacer (Sav-A-Caf; Milk Products LLC, Chilton, WI), 
containing all milk proteins, 20% CP and 20% fat, was fed to all calves. Gammulin (APC, Inc., 
Ankeny, IA) nutritional supplement was added to reconstituted milk replacer. Ingredients in 
Gammulin (Table 3.3) included bovine serum, fructooligosacharide (inulin), dried whey, 
maltodextrin, minerals, and vitamins.  Commercial starter (20% MomentaCalf Starter – RUM; 
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Vita Plus Corporation, Madison, WI) containing 20% CP was provided to all calves.  The 
ingredients are listed in Table 3.2.   
At arrival, calves were fed either AF or a control electrolyte solution (E). At the next 
feeding, all calves received the commercial calf milk replacer. The milk replacer contained either 
no G supplementation or was supplemented with G. Gammulin was supplemented twice daily by 
adding 25 g each feeding (50 g/d) to the reconstituted milk replacer. Milk replacers were 
reconstituted to 12.5% solids and fed at a rate of 10% of arrival BW in two feedings daily. 
Beginning on d 3 after arrival, milk replacers were fed at a rate of 12% of arrival BW for 2 wk, 
followed by 10% of arrival BW during wk 3 to 5. The G‐supplemented group received 50 g/d of 
G in the milk replacer during the first 14 d of feeding only. During wk 6, the afternoon milk 
replacer feeding was eliminated, and calves were weaned at d 42 after arrival. Commercial calf 
starter was provided daily for ad libitum intake from d 4 until d 56. Calves were fed at 0530 and 
1630 h each day; milk replacer, starter, and water intakes were recorded daily. Clean, fresh water 
was available at all times.  
Health 
 Calf health status was monitored throughout each day and assessed by daily assignment 
of scour scores and respiratory scores, as well as recording all medical treatments and elevated 
body temperatures. Fecal scores were recorded using the following guidelines: 1 = firm, well 
formed (not hard); 2 = soft, pudding-like; 3 = runny, pancake batter; 4 = liquid, splatters. Calves 
with high fecal scores (fecal score ≥ 3) that appeared depressed and dehydrated were treated with 
electrolytes during the day until fecal score decreased to 2 and behavior returned to normal. 
Calves with scours (fecal score ≥ 3) received an electrolyte solution (Land O’Lakes® electrolyte 
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system; Land O’Lakes Animal Milk Products Co.) 2 h post-feeding. Severely dehydrated calves 
received lactated Ringer’s solution intravenously and antibiotics as recommended by veterinary 
staff. Respiratory scores were also recorded once daily using the following guidelines: 1 = 
normal; 2 = runny nose; 3 = heavy breathing; 4 = cough-moist; 5 = cough-dry.  
Body temperatures were recorded daily until d 7, and at any time when a calf was 
depressed or off-feed.  As post-arrival protocol, all calves received 2.0 mL of Clostridium 
perfringens types C & D antitoxin (Boehringer Ingelheim, St. Joseph, MO) and 2.0 mL of 
Clostridium perfringens type A toxoid (Novartis Animal Health Inc., Larchwood, IA) 
subcutaneously 24 h and 14 d after arrival. At d 3, d 11, and wk 6 after arrival, 2.0 mL of 
Bovishield® Gold 5 (Pfizer Animal Health, Exton, PA) were administrated intramuscularly. All 
calves received a second dose of TVS-2 vaccine at d 14 after arrival. 
Data Collection 
Intakes and Body Growth Measurements. Individual intakes of milk replacer, starter, 
and water were measured and recorded daily.  Calves were measured for BW, withers height, 
body length, heart girth, hip height, and hip width at arrival and after the morning feeding on the 
same day each week until wk 8. 
 Blood Sampling and Analysis. Samples of blood were obtained at arrival (day 0) before 
the initial feeding and on d 2, 7, 14, and wk 4.  Blood samples were collected via jugular 
venipuncture using 20 G × 2.5-cm needles (Nipro Medical Corporation, Miami, FL), and placed 
into 10-mL Vacutainer serum tubes (Becton Dickinson; Franklin Lakes, NJ) containing clot 
activator. Samples were then centrifuged within 1 h of collection at 1300 rpm for 15 min in a                                                                                                                                                                                                                                                                                                                                             
centrifuge (Eppendorf model 5804; Brinkmann Instruments; Westbury, NY). After 
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centrifugation, the serum was removed, placed into 5-mL Falcon tubes (Becton Dickinson; 
Franklin Lakes, NJ), and stored at -20 °C until analysis.    
Serum from d 0, 2, 7, and 14 was analyzed for concentrations of IgG (d 0 only) and acid-
soluble protein, haptoglobin, cortisol, zinc, and albumin to determine evidence of stress 
response. Serum from wk 4 was analyzed for concentrations of urea N and total protein. 
Concentrations of albumin, urea N, and total protein were determined at the University of Illinois 
College of Veterinary Medicine clinical pathology laboratory using commercially available kits 
(Olympus America Inc., Center Valley, PA). Concentration of IgG was determined by radial 
immonodifusion (RID kit, VRMD Inc., Pullman, WA) by APC, Inc. Acid-soluble protein, 
haptoglobin, cortisol, and zinc were analyzed at Texas Tech University (courtesy of Dr. M. 
Ballou). Haptoglobin and zinc were determined as described by Makimura and Suzuki (1982) 
and Ballou et al. (2011) respectively. Cortisol was quantified using an enzyme immunoassay kit 
(Arbor Assays, Ann Arbor, MI) http://www.arborassays.com/products/inserts/K003-H5.pdf. 
Acid-soluble protein was determined using perchloric acid to precipitate most of the protein. The 
remaining protein concentration was measured; most of the acid soluble protein was alpha-1 acid 
glycoprotein. 
 Sampling and Analysis of Milk Replacers, Starter Grain, Arrival Formula, and 
Gammulin. For each replicate, milk replacer and starter grain were sampled weekly from wk 1 
to 8, while G was sampled during the supplementation period (wk 1 and 2). The AF was only 
offered and sampled on the arrival day for each replicate of calves. All samples were stored at -
20 °C and then composited by period and replicate. Composited samples were sent to a 
commercial laboratory (Dairy One Corporative Inc., Ithaca, NY), where they were analyzed for 
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concentrations of dry matter (DM), crude protein (CP), fat, and minerals by wet chemistry 
methods. 
Statistical Analysis 
Daily and weekly statistical analysis was performed using the GLIMMIX, MIXED, LOGISTIC 
and LIFETEST procedures of SAS (SAS v9.2 Institute Inc., Cary, NC). Growth, feed intakes, and 
health data were analyzed in in two periods: the first 2 wk (G supplementation period) and wk 1 
through wk 8 (entire research period). A linear mixed model (MIXED procedure) was 
constructed to analyze growth, feed intakes, and blood metabolites data. The model contained the 
fixed effects of AF and G, the interaction of AF and G, time (day or week), and interactions of 
time with AF and G.  Replicate and calf were considered random effects; calf was nested within 
replicate, AF, and G. The covariance structures considered for repeated measures analysis were 
compound symmetric, autoregressive order one, and unstructured. The covariance structure 
autoregressive order one yielded the lowest AICC value and was used in the models (Littell et 
al., 1998). Initial measurements of BW, withers height, body length, heart girth, hip height, hip 
width, and concentrations of plasma albumin, acid soluble protein, cortisol, haptoglobin, and 
zinc at d 0 were used as covariates when analyzing the respective data. Least squares means were 
calculated and are presented with standard errors of means (SEM). Degrees of freedom were 
estimated by using the Kenward-Roger method in the model statement. Residual distribution was 
evaluated for normality and homoscedasticity. 
Daily health data was analyzed using a multivariable logistic mixed models (GLIMMIX 
procedure) considering the count outcome variables number of calves having high fecal score 
(fecal score ≥ 3 in a 1 to 4 scale), number of days with high fecal score, percentage of calves 
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with high fecal score, number of calves with high respiratory score (respiratory score ≥ 3 in a 1 
to 5 scale), number of days with high respiratory score, and percentage of calves with high 
respiratory score.  The model contained the fixed effects of AF and G, the interaction of AF and 
G, time (week), and interactions of time with AF and G.  When the variance and mean of fecal 
and respiratory scores were evaluated, the data were found to be over-dispersed. To compensate 
for this, a negative binomial regression analysis was used to establish relationships of the fixed 
effects AF and G, and the interaction of AF and G. The coefficients in the log scale from 
negative binomial regression analysis are presented, as well as the odds ratios. 
Calf survival analysis was assessed using a Cox proportional hazard model (LIFETEST 
procedure). The fixed effects of AF, G, and the interaction of AF and G were treated as strata 
and forced in to the model. The assumption of the proportionality of hazard of the model was 
assessed graphically by plotting the logarithm of the hazard function versus the logarithm of 
time. Residuals were evaluated for homogeneous distribution. Finally, a logistic regression model 
(LOGISTIC procedure) considering the binary outcome variable MORTALITY was constructed. The 
odds ratio from main effects and treatments is described.  
In all statistical procedures significant differences were declared when P ≤ 0.05, and 
trends toward significant effects were noted when 0.06 ≤ P ≤ 0.10. 
RESULTS 
Temperature 
 Mean low and high ambient temperatures ranged from −5.2 to 16.2, −17.1 to 11.4, and 
−10.8 to 12.4 °C for replicates 1, 2, and 3, respectively. Ambient temperature was below the 
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lower critical temperature (Figure 3.1) most of the time throughout the study, indicating that 
calves would need to expend energy for thermoregulation (National Research Council, 2001). 
Nutrient Composition of Diets 
Nutrient composition of milk replacer and starter are listed in Table 3.1 and Table 3.2, 
respectively. Commercial milk replacer was declared to contain 20% CP on an as-fed basis and 
the actual analyzed CP (DM basis) was 22.0, 21.3, and 21.7% for replicates 1, 2, and 3, 
respectively. Similarly, commercial starter declared to contain 20% CP on an as-fed basis had 
measured CP content (DM basis) of 22.9, 23.3, and 24.6% for replicates 1, 2, and 3, respectively. 
Chemical analysis of the serum protein-based products, AF and G, indicated that CP content on a 
DM basis was 47.5% and 75.3%, respectively (Table 3.3). Although nutrient composition of 
milk replacer and starter were similar, G supplementation allowed greater CP intake in 
supplemented calves. 
Intakes 
Calves were fed a limited amount of milk replacer (10 to 12% of arrival BW) as 
described previously. Calves supplemented with G had greater (P < 0.0001) intake of milk 
replacer DM during the supplementation period because of the addition of G. Greater intake of 
milk replacer DM and supplementation with G resulted in higher (P < 0.0001) intake of milk 
replacer CP in G-supplemented calves (Table 3.4). As part of limited liquid feeding, calf starter 
was offered ad libitum from d 4 to help meet nutrient requirements and support growth. 
Although the amount of starter intake during the first 2 wk was not large, calves fed AF had 
greater (P = 0.0007) intake of DM and CP from starter. As a result of greater intake of DM and 
CP from milk replacer and starter, calves fed AF (P = 0.04) and those supplemented with G (P < 
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0.0002) had greater intakes of total DM and total CP at 2 wk (Table 3.4). Greater starter intake in 
AF-fed calves led to greater starter ME intake (P = 0.0007) and greater (P = 0.04) total ME 
intake (Table 3.4).  Trends toward significance were observed in the interaction AF × G for 
intakes of milk replacer DM (P = 0.08), CP (P = 0.07), and ME (P = 0.08). As discussed 
previously, supplementation of the high-CP G supplement resulted in calves fed AFG or EG 
having superior milk replacer DM (P ≤ 0.002) and CP (P < 0.0001) intakes compared with 
calves fed AF or E. Additionally, calves fed the EG treatment had greater (P = 0.04) intake of 
ME from milk replacer than calves receiving the E treatment (Table 3.4). 
Water intake was analyzed in different components: free water, water in milk replacer, 
water in feed, and total water intake. Water freely available at all times was considered as free 
water. Water in milk replacer was the water used to reconstitute the milk replacer. Water in feed 
was the water contained in the as-fed starter and milk replacer powder. Total water was the sum 
of all sources of water.  There was no difference in intakes of free water, water in milk replacer, 
or total water; however, there was statistical difference in water in feed for calves fed AF (P = 
0.008) or G (P = 0.02) (Table 3.4). These differences were small and likely were not biologically 
significant.  
Through 8 wk, intakes were not affected by the main effects of AF or G except for milk 
replacer DM and CP intake (Table 3.5). Greater mean intake (P < 0.0001) of milk replacer DM 
and CP at 8 wk was the result of increased intake of milk replacer DM and CP at 2 wk (Table 
3.5) as designed.  At 8 wk, significant interactions of G × week were observed for milk replacer 
DM (P < 0.0001), milk replacer CP (P < 0.0001), and total CP intake (P = 0.002). Milk replacer 
DM and CP intake increased from wk 1 to wk 2 and were greater for G-supplemented calves as 
designed (P < 0.0001). After the second week, intakes of G-supplemented calves decreased and 
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became similar to intakes of non-G-supplemented calves because of the removal of G from the 
diet (Figure 3.2, Panels A and B, respectively). Total CP intake was higher (P = 0.06) at 2 wk for 
calves supplemented with G; from the second week total CP intake was similar for supplemented 
and non-supplemented calves (Figure 3.2, Panel C).  
Growth 
Initial calf BW and body conformation measures did not differ among treatment groups 
(Table 3.6). Differences at 2 wk were not evident; neither AF nor G had a great effect in most 
growth parameters at this time. For instance, withers height and hip height was not affected by G 
supplementation. However, calves fed AF had greater (P = 0.05) body length and tended to have 
greater (P = 0.07) heart girth; whereas, calves supplemented with G tended to have greater (P = 
0.06) BW (Table 3.6).  
Through 2 wk, the G × week interaction was significant for average daily gain (ADG, P 
= 0.03) and feed efficiency (gain: feed, P = 0.05) (Table 3.6). The G-supplemented calves had 
greater ADG (P = 0.01) and tended to have superior (P = 0.06) feed efficiency in the first week 
(Figure 3.3). At wk 2, differences were not significant between G-supplemented and non-G-
supplemented calves (Figure 3.3). The interaction AF × G × week was significant for body 
length (P = 0.02), heart girth (P = 0.01), and hip width (P = 0.01) (Table 3.6). In the first week, 
calves fed AFG treatment had longer (P = 0.02) body length (Figure 3.4, Panel A) and tended to 
have greater (P = 0.08) heart girth (Figure 3.4, Panel B) than EG-fed calves. In the second week, 
AF-fed calves had greater heart girth (P = 0.02; Figure 3.3, Panel B) and hip width (P = 0.01; 
Figure 3.3, Panel C), and tended to have bigger hip width (P = 0.06, Figure 3.3, Panel C) than 
calves on the other treatments. 
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At 8 wk, BW and body conformation parameters, except for hip width, were similar for 
all groups of calves. Calves fed AF exhibited greater (P = 0.04) hip width (Table 3.7) but 
differences were numerically small. The interaction AF × G was significant for hip height. 
Calves fed AFG or E treatments had greater (P = 0.05) hip height than EG-fed calves (Table 
3.7).  
The G × week interaction was significant for ADG (P = 0.02), gain: feed (P < 0.0001), 
and tended to be significant (P = 0.06) for withers height. Through the entire experiment, 
differences in ADG were not evident, except in the first week where G- supplemented calves had 
superior (P = 0.03) ADG compared to non-supplemented calves (Figure 3.5, Panel A). Feed 
efficiency was greater (P = 0.0006) for G-supplemented calves in the first week only, then 
became lower (P ≤ 0.02) until wk 4 for these same calves. After wk 5, differences in feed 
efficiency among G-supplemented and non-G-supplemented calves were not detected (Figure 
3.5, Panel B). Finally, withers height was greater (P = 0.02) for calves supplemented with G at 
wk 8 only (Figure 3.5, Panel C). 
The interaction AF × G × week tended (P = 0.08) to be significant for body length (Table 
3.7). Differences were not significant among treatments through the 8 wk of the study except for 
calves fed the EG treatment, which exhibited smaller (P < 0.05) body length from wk 5 (Figure 
3.6). 
Health 
Supplementation with G influenced health during the supplementation period. 
Supplemented calves had lower (P = 0.01) mean respiratory score (Table 3.8), less odds for days 
(OR = 0.33, P = 0.008) with high respiratory score, and lower odds for both number (OR = 0.32, 
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P = 0.0008) and percentage (OR = 0.30, P = 0.001) of calves with high respiratory score (Table 
3.10). Calves fed treatment AFG also presented smaller (OR = 0.18, P = 0.008) odds for 
percentage of calves with high respiratory score (Table 3.10). The interaction of the main effect 
AF and week was significant (P = 0.01) for fecal score (Table 3.8); calves fed AF had decreased 
(P = 0.04) mean fecal score during the first 2 wk (Figure 3.7).  
Over the entire 8 wk, G supplementation also influenced health status. Thus, G-
supplemented calves had lower (P = 0.02) mean fecal scores (Table 3.9). Although there was no 
difference in electrolyte treatments, calves supplemented with G received fewer (P = 0.05) 
antibiotic treatments than calves without G supplementation (Table 3.11). Throughout the study, 
mortality occurred during the first 3 wk and was higher (P = 0.02) for non-G-supplemented 
calves (Figure 3.8). Accordingly, G-supplemented calves had lower mortality odds (OR = 0.12, 
P = 0.04) during the 56 d of the experiment (Table 3.10). Analysis of plasma IgG revealed that 
concentration of IgG was significantly lower (P = 0.008) in calves that died compared to those 
that survived (Figure 3.9).  
Blood Metabolites 
Total plasma protein measured by refractometry upon arrival, to stratify and block the 
calves; total plasma protein analyzed by cobas, and plasma IgG determined by radial 
immonodifusion several weeks after arrival were not different among treatments (Figure 3.10). 
Although blood metabolite concentrations were statistically different (P < 0.05) in time, the main 
effects and interactions were not significant for plasma concentrations of albumin, haptoglobin, 
zinc, and ASP (Table 3.12).  Plasma cortisol, on the other hand, was affected by the main effect 
of AF. Calves fed AF exhibited higher (P = 0.02) concentrations of cortisol in plasma than E-fed 
48 
 
calves. Interactions of main effects and time also were not significant for plasma cortisol. 
Likewise, the main effect of G was significant for urea N and total protein. As a result, calves 
supplemented with G had greater concentrations of total protein (P = 0.04) and urea N (P = 0.01) 
in plasma at wk 4 (Table 3.12). 
DISCUSSION 
Serum protein products had only small effects on growth and intakes in this study, but 
health status, morbidity, and mortality were significantly improved. Fecal score, incidence of 
scours, and respiratory problems decreased during the supplementation period. Improved health 
in serum protein-supplemented calves led to less antibiotic use, decreased morbidity, and less 
mortality. Arthington et al. (2000a) reported fewer treatments for illness when calves were fed 
bovine serum as an IgG source at birth and 12 h later. Lower mortality and improved indices of 
enteric health (improved fecal scores, fewer days with diarrhea, and lower use of electrolyte) 
were reported by Quigley et al. (2002) when additives containing bovine serum or milk replacer 
containing spray-dried plasma were fed to calves. Similarly, Arthington et al. (2002) reported 
improvement in average respiratory rate of calves infected with coronavirus when bovine serum 
was supplemented. Reduced calf morbidity and mortality also were reported by Quigley and 
Wolfe (2003) with inclusion of spray-dried bovine or porcine plasma in milk replacer.  
Serum protein-based AF contained spray-dried bovine serum, minerals, and vitamins. 
Gammulin contains the same components as AF plus fructooligosaccharides (Quigley  et al., 
2002). Bovine serum is a source of immunoglobulins that might provide intestinal protection 
against enteric pathogens (Arthington et al., 2000a; Arthington et al., 2002; Quigley et al., 2002; 
Quigley and Wolfe, 2003). Fructooligosaccharides may increase the growth and population of 
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beneficial intestinal microorganisms, improving intestinal health and decreasing incidence of 
diseases (Grizard and Barthomeuf, 1999; Menne et al., 2000).  
Improvements in health for calves supplemented with G might be related to greater 
nutrient intake in those calves.  Supplementation with G led to greater intake of milk replacer 
DM and CP during the first 2 wk. Supplemental G resulted in G × week interactions for ADG 
during the first 2 wk, showing that growth was improved. These results agree with Quigley et al. 
(2002) and Quigley and Wolfe (2003) who reported, even though minimal, an increase in milk 
replacer intake when spray-dried serum or plasma (either from bovine or porcine origin) were 
fed to calves. In other species similar results were described; Pierce et al. (2005) reported 
enhanced feed intakes when spray-dried plasma was fed to early weaned pigs. Supplementation 
with serum protein and greater intakes of DM and CP during the first 2 wk improved BW, ADG, 
and feed efficiency during early serum protein supplementation. In a 56-d experiment, Quigley et 
al. (2002) found a 12.9% increase in BW gain from d 29 to 56 when serum protein was 
supplemented to calves. Morrill et al. (1995) also reported greater BW gain when calves were 
fed milk replacer containing plasma protein of bovine or porcine origin. However, Quigley et al. 
(2000) did not see a change in calf performance when spray-dried red blood cells were tested in 
milk replacer. 
Although all measures were not significant, the single dose of AF given at arrival resulted 
in weak tendencies for greater growth during wk 1 to 2, as shown by small increases in final BW 
(P = 0.17), heart girth (P = 0.07), body length (P = 0.05), hip height (P = 0.19), hip width (P = 
0.13), and ADG (P = 0.15).  These tendencies may be related to the stimulation of starter intake 
during the first 2 wk.  Greater early starter intake in stressed calves would be a benefit in terms 
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of growth and resistance to disease.  The improved early growth is in agreement with Jones et al. 
(2004) who fed a colostrum replacement derived from bovine serum at 1.5 and 13.5 h of age.   
Although concentrations of albumin, haptoglobin, zinc, and ASP were statistically 
different by day they remained within the considered normal ranges. Plasma cortisol 
concentrations in AF-fed calves were greater than those in calves fed E, but concentrations were 
still very much lower than values of 38.0 ng/mL and 79.0 ng/mL reported by Khan et al. (1970) 
and Willett and Erb (1972), respectively. Thus, these increases in our study were small and likely 
cannot be considered biologically elevated.  Increases may be related to the greater protein intake 
during the first electrolyte feeding.   
Increased concentrations of urea N and total protein in plasma at wk 4 may have been the 
result of greater intake of CP during G supplementation. Tendency toward greater plasma protein 
status was observed by Quigley et al. (2002) and Jones et al. (2004) when feeding milk replacer 
containing spray-dried bovine plasma.  However, it must be noted that the wk 4 samples were 
taken 2 wk after G supplementation was discontinued, indicating that the improved protein status 
was in some way a residual effect of early G supplementation. 
CONCLUSIONS 
Feeding a serum protein product to pre-weaned dairy calves that were exposed to 
stressors of transport and cold weather resulted in little improvement of early feed intakes and 
growth but significantly decrease morbidity and mortality. The serum protein-based AF 
promoted starter intake, growth, and improved fecal score during the first 2 wk. Similarly, G 
supplementation stimulated early milk replacer intake and growth, decreased incidence of 
respiratory problems at 2 wk, and significantly decreased mortality. Indicators of acute-phase 
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response were not affected by AF or G; however, protein status of calves assessed at 4 wk after 
arrival may have been improved by G supplementation during the first 2 wk.  
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Table 3.1. Analyzed chemical composition of milk replacer by group (replicate) of calves¹. 
 Group of Calves  
Item 1 2 3 Mean 
DM, % 94.3 93.0 94.1 93.8 
CP, % of DM 22.0 21.3 21.7 21.7 
Crude fat, % of DM 18.7 18.8 19.1 18.9 
Ash, % of DM 10.1 9.8 10.2 10.0 
TDN, % of DM 105 105 105 105 
NEL, Mcal/kg 2.71 2.72 2.72 2.72 
NEM, Mcal/kg 2.66 2.67 2.67 2.67 
NEG, Mcal/kg 1.90 1.90 1.90 1.90 
Ca, % of DM 0.74 0.74 0.74 0.74 
P, % of DM 0.72 0.70 0.75 0.72 
Mg, % of DM 0.14 0.14 0.14 0.14 
K, % of DM 2.30 2.19 2.32 2.27 
Na, % of DM 0.99 0.97 1.00 0.99 
S, % of DM 0.31 0.32 0.32 0.32 
Fe, ppm 59 115 133 102 
Zn, ppm 52 59 60 57 
Cu, ppm 9 10 3 7 
Mn, ppm 37 34 42 38 
Mo, ppm  0.7 0.8 1.0 0.8 
¹ Manufacturer’s indicated list of ingredients: Dried whey, dried whey protein concentrate, 
animal fat (preserved with BHA, BHT, citric acid, and ethoxyquin), dried whey product, dried 
skimmed milk, calcium carbonate, L-lysine, sodium silico aluminate, DL-methionine, ferrous 
sulfate, magnesium sulfate, choline chloride, artificial flavor, vitamin E supplement, 
maltodextrin, selenium yeast, brewer's dried yeast, vitamin A supplement, zinc sulfate, lecithin, 
ethoxylated mono-diglycerides, propylene glycol, manganese sulfate, copper sulfate, ascorbic 
acid, niacin supplement, vitamin D3 supplement, calcium pantothenate, menadione sodium 
bisulfite complex, biotin, riboflavin supplement, thiamine mononitrate, pyridoxine 
hydrochloride, vitamin B12 supplement, folic acid, cobalt sulfate. 
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Table 3.2. Analyzed chemical composition of starter grain by group (replicate) of calves¹. 
 Group of Calves  
Item 1 2 3 Mean 
DM, % 87.5 88.0 88.2 87.9 
CP, % of DM 22.9 23.3 24.6 23.6 
ADF, % of DM 6.0 6.2 8.0 6.7 
NDF, % of DM 12.1 13.9 14.0 13.3 
TDN, % of DM 83 83 83 83 
NEL, Mcal/kg 2.06 2.04 2.05 2.05 
NEM, Mcal/kg 2.15 2.13 2.14 2.14 
NEG, Mcal/kg 1.47 1.46 1.47 1.47 
Ca, % of DM 1.23 1.15 1.20 1.19 
P, % of DM 0.60 0.61 0.64 0.62 
Mg, % of DM 0.27 0.29 0.30 0.29 
K, % of DM 1.14 1.20 1.22 1.19 
Na, % of DM 0.25 0.23 0.31 0.26 
Fe, ppm 293 301 322 305 
Zn, ppm 147 135 125 136 
Cu, ppm 25 22 23 23 
Mn, ppm 105 97 119 107 
Mo, ppm  1.5 1.3 1.3 1.4 
¹ Manufacturer’s indicated list of ingredients: Steam flaked corn, soybean meal, oats, cane 
molasses, fat product feed grade, heat processed soybeans, canola meal, wheat middlings, corn 
destillers dried grains, calcium carbonate, monocalcium phosphate, dicalcium phosphate, salt, 
dried whey solubles, magnesium sulfate, potassium sulfate, propionic acid, ammonium 
hydroxide, acetic acid, benzoic acid, sorbic acid, tartaric acid, sodium sesquicarbonate, zinc 
sulfate, manganese sulfate, copper sulfate, calcium iodate, cobalt carbonate, vitamin E 
supplement, selenium yeast, brewer's dried yeast, artificial flavor, dextrose, saccharine sodium, 
yeast culture, choline chloride, vitamin A supplement, vitamin D3 supplement, ferrous sulfate, 
niacin supplement, calcium pantothenate, vitamin B12 supplement, riboflavin, supplement, 
thiamine mononitrate, menadione sodium bisulfite complex, pyridoxine hydrochloride. 
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Table 3.3. Analyzed chemical composition of Gammulin¹ and Arrival Formula². 
Item Gammulin Arrival Formula 
DM, % 93.5 90.6 
CP, % of DM 75.3 47.5 
Crude fat, % of DM 1.6 4.5 
Ash, % of DM 6.1 12.3 
Ca, % of DM 0.87 0.81 
P, % of DM 0.26 0.17 
Mg, % of DM 0.07 0.10 
K, % of DM 0.18 0.85 
Na, % of DM 1.11 2.32 
S, % of DM 1.11 0.67 
Fe, ppm 131 121 
Zn, ppm 358 121 
Cu, ppm 89 5 
Mn, ppm 160 57 
Mo, ppm  0.8 0.6 
¹ Manufacturer’s indicated list of ingredients: Bovine serum, inulin, dried whey, maltodextrin, 
sorbitol, calcium carbonate, DL-methionine, magnesium sulfate, lecithin, mineral oil, silicon 
dioxide, choline chloride, polyoxyethylene glycol (400) mono and dioleates, dried whey protein 
concentrate, dicalcium phosphate, natural and artificial flavors, zinc sulfate, vitamin E 
supplement, manganese sulfate, vitamin A acetate, copper sulfate, ascorbic acid, calcium iodate, 
vitamin D3 supplement, vitamin B12 supplement, sodium selenite, niacinamide, calcium 
pantothenate, biotin, menadione sodium bisulfite complex, sodium bicarbonate, folic acid, 
riboflavin, pyridoxine hydrochloride, cobalt sulfate, thiamine mononitrate. 
² Manufacturer’s indicated list of ingredients: Spray dried bovine serum, dextrose, animal and 
vegetable fat (preserved with BHA and BHT), sodium citrate, glycine, dried whey, salt, 
potassium chloride, dried whey protein concentrate, calcium carbonate, sodium acetate, calcium 
lactate, fructose, lecithin, magnesium sulfate, choline chloride, natural and artificial flavors, 
vitamin E supplement, silicon dioxide, mineral oil, emulsifier, zinc proteinate, dicalcium 
phosphate, ferrous sulfate, manganese proteinate, vitamin A acetate, selenium yeast, brewer’s 
dried yeast, iron proteinate, ascorbic acid, calcium pantothenate, vitamin B12 supplement, 
vitamin D3 supplement, niacinamide, riboflavin, biotin, pyridoxine hydrochloride, thiamine 
mononitrate, folic acid, calcium iodate, menadione sodium bisulfite complex, cobalt sulfate. 
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Table 3.4. Mean daily intakes of dry matter (DM), crude protein (CP), and metabolizable energy (ME) from milk replacer and starter, and 
water intake from wk 1 to wk 2 for calves fed electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk replacer 
without Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Total DM, g/d 555.6 599.3 624.3 638.8 19.7 0.03 0.0002 0.28 0.24 0.91 0.41 
    Milk replacer DM, g/d 522.6 540.6 594.3 579.8 20.2 0.85 <.0001 0.08 0.32 0.62 0.16 
    Starter DM, g/d 34.2 58.3 30.1 58.7 7.4 0.0007 0.80 0.76 0.41 0.55 0.94 
Total CP, g/d 121.1 131.1 160.9 163.8 5.2 0.04 <.0001 0.27 0.26 0.71 0.42 
    Milk replacer CP, g/d 113.3 117.2 153.8 150.1 5.4 0.97 <.0001 0.07 0.37 0.20 0.18 
    Starter CP, g/d 8.05 13.80 7.08 13.72 1.74 0.0007 0.76 0.79 0.42 0.54 0.95 
Total ME, Mcal/d 2.31 2.48 2.41 2.45 0.08 0.05 0.49 0.24 0.22 0.76 0.35 
    Milk replacer ME, Mcal/d 2.20 2.28 2.31 2.25 0.08 0.79 0.29 0.08 0.30 0.90 0.15 
    Starter ME, Mcal/d 0.11 0.19 0.10 0.20 0.02 0.0007 0.80 0.76 0.41 0.55 0.94 
Total water intake, kg/d 4.56 4.81 4.73 4.60 0.22 0.63 0.88 0.12 0.46 0.77 0.61 
    Free water, kg/d 0.60 0.99 0.60 0.56 0.29 0.29 0.20 0.21 0.27 0.48 0.84 
    Water in milk replacer, kg/d 3.90 4.03 4.09 3.99 0.13 0.79 0.29 0.08 0.30 0.90 0.15 
    Water in feed¹, kg/d 0.04 0.04 0.04 0.05 0.002 0.008 0.02 0.60 0.26 0.95 0.76 
¹ Water in starter and milk replacer powder. 
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Table 3.5. Mean daily intakes of dry matter (DM), crude protein (CP), and metabolizable energy (ME) from milk replacer and starter, and 
water intake from wk 1 to wk 8 for calves fed electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk replacer without 
Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
 Treatment     P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Total DM, g/d 1251.0 1255.1 1203.6 1265.1 40.4 0.41 0.64 0.47 0.64 0.59 0.33 
    Milk replacer DM, g/d 480.7 478.9 504.0 500.0 19.3 0.23 <.0001 0.64 0.94 <.0001 0.16 
    Starter DM, g/d 891.9 895.8 824.9 889.4 43.7 0.38 0.34 0.43 0.67 0.87 0.36 
Total CP, g/d 287.8 289.3 285.8 300.1 9.1 0.38 0.63 0.48 0.65 0.002 0.34 
    Milk replacer CP, g/d 104.2 103.8 121.9 120.8 5.1 0.22 <.0001 0.55 0.92 <.0001 0.17 
    Starter CP, g/d 210.8 211.1 194.3 209.3 9.4 0.35 0.18 0.47 0.67 0.85 0.38 
Total ME, Mcal/d 4.55 4.57 4.34 4.54 0.13 0.40 0.37 0.48 0.65 0.86 0.33 
    Milk replacer ME, Mcal/d 2.02 2.02 2.02 2.01 0.08 0.23 0.57 0.68 0.95 0.79 0.16 
    Starter ME, Mcal/d 3.04 3.05 2.81 3.03 0.14 0.38 0.34 0.43 0.67 0.87 0.37 
Total water intake, kg/d 4.88 5.08 4.67 4.83 0.18 0.20 0.10 0.89 0.70 0.68 0.75 
    Free water, kg/d 2.06 2.25 1.85 2.02 0.13 0.17 0.10 0.93 0.71 0.76 0.93 
    Water in milk replacer, kg/d 3.59 3.57 3.58 3.56 0.13 0.22 0.56 0.68 0.95 0.79 0.16 
    Water in feed¹, kg/d 0.15 0.15 0.14 0.15 0.01 0.39 0.26 0.45 0.74 0.08 0.88 
¹ Water in starter and milk replacer powder. 
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Table 3.6. Initial and final body weight (BW), final body conformation measurements, average daily gain (ADG), and feed 
efficiency from wk 1 to wk 2 for calves electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk replacer 
without Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival formula plus milk replacer with Gammulin 
(AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Initial BW, kg 42.7 42.7 42.6 42.6 0.40 -- -- -- -- -- -- 
Final BW, kg 45.6 46.5 46.4 47.0 0.70 0.17 0.06 0.96 0.39 0.52 0.35 
Heart girth, cm 81.2 82.2 81.5 81.7 0.59 0.07 0.72 0.94 0.52 0.67 0.01 
Body length, cm 66.6 67.0 66.5 66.8 0.37 0.05 0.82 0.17 0.48 0.66 0.02 
Withers height, cm 79.9 79.9 79.8 79.9 0.20 0.65 0.38 0.49 0.76 0.24 0.47 
Hip height, cm 84.0 84.1 84.0 84.4 0.22 0.19 0.97 0.40 0.96 0.19 0.76 
Hip width, cm 17.6 17.9 17.6 17.7 0.11 0.13 0.85 0.72 0.19 0.20 0.01 
ADG, kg/d 0.20 0.27 0.26 0.30 0.05 0.15 0.24 0.72 0.98 0.03 0.29 
G:F 0.36 0.45 0.43 0.45 0.08 0.32 0.54 0.61 0.83 0.05 0.30 
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Table 3.7. Initial and final body weight (BW), final body conformation measurements, average daily gain (ADG), and feed 
efficiency from wk 1 to wk 8 for calves electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk replacer 
without Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival formula plus milk replacer with Gammulin 
(AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Initial BW, kg 42.7 42.6 42.6 42.6 1.2 -- -- -- -- -- -- 
Final BW, kg 82.2 81.0 79.0 81.0 1.2 0.52 0.50 0.55 0.78 0.13 0.77 
Heart girth, cm 100.4 100.0 99.4 99.6 0.57 0.29 0.26 0.85 0.82 0.87 0.19 
Body length, cm 78.8 78.2 77.6 78.7 0.66 0.20 0.26 0.12 0.78 0.93 0.08 
Withers height, cm 89.2 88.5 88.0 88.2 0.35 0.85 0.35 0.19 0.57 0.06 0.52 
Hip height, cm 93.1 92.2 91.6 92.6 0.32 0.69 0.55 0.03 0.65 0.32 0.25 
Hip width, cm 21.9 22.0 21.4 21.9 0.16 0.04 0.30 0.94 0.43 0.18 0.14 
ADG, kg/d 0.71 0.69 0.65 0.69 0.03 0.78 0.36 0.37 0.62 0.02 0.85 
Gain:feed 0.56 0.55 0.53 0.53 0.02 0.82 0.21 0.83 0.60 <.0001 0.96 
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Table 3.8. Mean daily fecal score (FS) and respiratory score (RS), coefficients for days with high FS and RS, coefficients for number of 
calves with high FS and RS, and coefficients for percentage of calves with high FS¹ and RS² from wk 1 to wk 2 for calves fed electrolyte 
plus milk replacer without Gammulin (E), arrival formula plus milk replacer without Gammulin (AF); electrolyte plus milk replacer with 
Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Days in trial 14 14 14 14 -- -- -- -- -- -- -- 
Calves per treatment 25 24 22 22 -- -- -- -- -- -- -- 
Fecal score            
    Mean fecal score 2.7 2.7 2.6 2.6 0.14 0.72 0.25 0.82 0.01 0.14 0.65 
    Days with high FS* 1.8 1.8 1.7 1.8 0.11 0.78 0.61 0.65 -- -- -- 
    High FS, no. of calves* 2.4 2.3 2.2 2.3 0.09 0.75 0.25 0.28 0.05 0.27 0.94 
    Calves with high FS*, % 3.8 3.8 3.7 3.8 0.11 0.87 0.59 0.75 0.11 0.21 0.68 
Respiratory score            
    Mean respiratory score 1.1 1.2 1.1 1.0 0.06 0.63 0.01 0.47 0.44 0.87 0.92 
    Days with high RS* -0.2 0.0 -0.7 -1.7 0.40 0.31 0.008 0.15 -- -- -- 
    High RS, no. of calves* 0.3 0.6 -0.3 -1.1 0.30 0.43 0.0008 0.10 0.26 0.84 0.89 
    Calves with high RS*, % 1.8 2.0 1.3 0.1 0.34 0.17 0.001 0.05 0.19 0.64 0.54 
¹ High FS: calves with fecal score ≥ 3 (1-4 scale). 
² High RS: calves with respiratory score ≥ 3 (1-5 scale). 
* Coefficients in the log scale from negative binomial regression analysis. 
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Table 3.9. Mean daily fecal score (FS) and respiratory score (RS), coefficients for days with high FS and RS, coefficients for number of 
calves with high FS and RS, and coefficients for percentage of calves with high FS¹ and RS² from wk 1 through 8 for calves fed electrolyte 
plus milk replacer without Gammulin (E), arrival formula plus milk replacer without Gammulin (AF); electrolyte plus milk replacer with 
Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G AF*wk G*wk AF*G*wk 
Days in trial 56 56 56 56 -- -- -- -- -- -- -- 
Calves per treatment 25 24 22 22 -- -- -- -- -- -- -- 
Fecal score            
    Mean fecal score 1.7 1.7 1.6 1.6 0.09 0.92 0.02 0.80 0.20 0.66 0.16 
    Days with high FS* 2.2 2.1 1.9 1.9 0.12 0.86 0.16 0.55 -- -- -- 
    High FS*, no. of calves 0.7 0.5 -1.5 0.1 0.16 0.97 0.96 0.97 0.43 0.11 0.44 
    Calves with high FS*, % 2.2 2.1 -0.1 1.7 0.13 0.97 0.95 0.96 0.52 0.01 0.18 
Respiratory score            
    Mean respiratory score 1.0 1.0 1.0 1.0 0.04 0.64 0.96 0.62 0.68 0.16 0.78 
    Days with high RS* -0.1 0.0 -0.7 0.0 0.44 0.34 0.51 0.45 -- -- -- 
    High RS, no. of calves* -1.4 -1.5 -1.6 -1.1 0.30 0.48 0.91 0.33 0.81 0.29 0.75 
    Calves with high RS*, % -7.0 -10.6 -10.8 -1.5 148.4 0.98 0.98 0.96 0.96 1.00 0.99 
¹ High FS: calves with fecal score ≥ 3 (1-4 scale). 
² High RS: calves with respiratory score ≥ 3 (1-5 scale). 
* Coefficients in the log scale from negative binomial regression analysis. 
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Table 3.10. Odds ratio of high respiratory score (RS¹) from wk 1 to wk 2 and mortality from wk 1 through 8 for calves fed electrolyte 
plus milk replacer without Gammulin (E), arrival formula plus milk replacer without Gammulin (AF); electrolyte plus milk replacer 
with Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
Variable Main Effect Treatment Level Odds Ratio 95% CI² P 
High RS, no. of calves Gammulin -- G/NG 0.32 0.17 – 0.60 0.0008 
          
Calves with high RS, % Gammulin -- G/NG 0.30 0.15 – 0.59 0.001 
 -- EG EG/E 1.24 0.50 – 3.07 0.63 
 -- AF AF/E 0.59 0.23 – 1.50 0.26 
 -- AFG AFG/E 0.18 0.06 – 0.52 0.001 
       
Days with high RS Gammulin  G/NG 0.33 0.14 – 0.75 0.008 
       
Mortality Gammulin -- G/NG 0.12 0.01 – 1.00 0.04 
 Arrival formula -- AF/E 0.80 0.20 – 3.19 0.07 
 -- AF AF/E 1.05 0.23 – 0.48 0.93 
 -- EG EG/E 0.25 0.03 – 2.43 0.96 
 -- AFG AFG/E 0.00 0.00 – 999 0.94 
¹ High RS: calves with respiratory score ≥ 3 (1-5 scale). 
² CI: confidence interval derived from a negative binomial regression. 
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Table 3.11. Mortality, serum IgG, plasma protein, electrolyte³ and antibiotic4 treatment from wk 1 
through 8 for calves fed electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk 
replacer without Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival 
formula plus milk replacer with Gammulin (AFG).   
 Treatment  P 
Variable E AF EG AFG SEM AF G AF*G 
Calves per treatment 25 24 22 22 -- -- -- -- 
Calves died per treatment 4 4 1 0 -- -- -- -- 
Mortality, % 16 16 5 0 -- -- -- -- 
Mean age at mortality, d 16 7 8 -- -- -- -- -- 
IgG¹, g/dL 9.8 14.2 13.8 13.5 2.1 0.23 0.31 0.17 
Plasma protein², g/dL 5.60 5.71 5.59 5.67 0.19 0.82 0.60 0.76 
Electrolyte, # treatments/calf  9.6 7.4 6.0 4.3 2.7 0.97 0.32 0.11 
Antibiotic, # treatments/calf 2.8 2.3 1.0 2.1 0.64 0.59 0.05 0.10 
¹ Measured on day of arrival (d 0). SD: E = ±6.53, AF = ±11.91, EG = ± 7.72, and AFG = ±5.45.   
² Measured on day of arrival (d 0) by refractometry. 
³ Electrolyte: 77 g of Land O’Lakes electrolyte mixed in 2 L of water. 
4 Antibiotics: individual administration of tetracycline, penicillin, ceftiofur, or tulathromycin as 
recommended by manufacturer. 
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Table 3.12. Blood metabolites for calves fed electrolyte plus milk replacer without Gammulin (E), arrival formula plus milk replacer 
without Gammulin (AF); electrolyte plus milk replacer with Gammulin (EG); or arrival formula plus milk replacer with Gammulin (AFG).   
 Treatment   P 
Variable  E AF EG AFG SEM AF G AF*G d AF*d G*d AF*G*d 
Albumin¹, g/dL 2.58 2.33 2.48 2.55 0.10 0.34 0.55 0.11 <0.0001 0.60 0.25 0.29 
Cortisol¹, ng/mL 13.3 17.8 14.5 16.2 1.37 0.02 0.89 0.29 <0.0001 0.62 0.61 0.52 
Haptoglobin¹, OD*100    2.83 2.56 2.29 2.54 0.32 0.97 0.23 0.27 0.008 0.14 0.94 0.64 
Zinc¹, ppm 1.21 1.20 1.18 1.20 0.07 0.94 0.66 0.77 <0.0001 0.36 0.87 0.17 
ASP¹, μg/mL 251 261 238 251 8.50 0.18 0.21 0.86 <0.0001 0.81 0.28 0.87 
Urea N², mg/dL 6.04 6.37 7.59 7.36 0.52 0.91 0.01 0.59 -- -- -- -- 
Total protein², g/dL  4.01 4.16 4.60 4.90 0.32 0.48 0.04 0.80 -- -- -- -- 
¹ Measured on day of arrival (d 0) and d 2, 7, and 14. 
² Measured on wk 4. 
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Figure 3.1. Mean high and low ambient temperature during research period by group of calves.  
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Figure 3.2. Mean daily intake of milk replacer DM, milk replacer CP, and total CP for calves 
supplemented with Gammulin ( ) or not supplemented with Gammulin ( ). Panel A: 
milk replacer DM intake from wk 1 to wk 6. G x wk: P < 0.0001. Panel B: milk replacer CP 
intake from wk 1 to wk 6. G x wk: P < 0.0001. Panel C: total CP intake from wk 1 to wk 8. G x 
wk: P = 0.002.  
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Figure 3.3. Average daily gain (ADG) and feed efficiency (gain: feed) from wk 1 to wk 2 for 
calves supplemented with Gammulin ( ) or not supplemented with Gammulin ( ). Panel 
A: ADG, G x wk: P = 0.03. Panel B: gain: feed, G x wk: P = 0.05.  
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Figure 3.4. Body length, heart girth, and hip width from wk 1 to wk 2 for calves fed arrival 
formula plus milk replacer with Gammulin ( ); arrival formula plus milk replacer without 
Gammulin ( ); electrolyte plus milk replacer with Gammulin ( ); or electrolyte plus milk 
replacer without Gammulin ( ). Panel A: body length, AF x G x wk: P = 0.02. Panel B: 
heart girth, AF x G x wk: P = 0.01. Panel C: hip width, AF x G x wk: P = 0.01.  
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Figure 3.5. Average daily gain (ADG), feed efficiency (gain: feed), and withers height from wk 
1 to wk 8 for calves supplemented with Gammulin ( ) or not supplemented with Gammulin (
). Panel A: ADG, G x wk: P = 0.02. Panel B: gain: feed, G x wk: P < 0.0001. Panel C: 
withers height, G x wk: P = 0.06.  
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Figure 3.6. Body length from wk 1 to wk 8 for calves fed arrival formula plus milk replacer with 
Gammulin ( ); arrival formula plus milk replacer without Gammulin ( ); electrolyte plus 
milk replacer with Gammulin ( ); or electrolyte plus milk replacer without Gammulin (
); AF x G x wk: P = 0.08.    
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Figure 3.7. Fecal score from wk 1 to wk 2 for calves fed arrival formula ( ) or electrolyte (
). AF x wk: P = 0.01.   
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Figure 3.8. Survival percentage from wk 1 to wk 8 for calves supplemented with Gammulin (
) or not supplemented with Gammulin ( ). P = 0.02. 
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Figure 3.9. Mean plasma IgG, determined by radial immonodifusion, at arrival day before 
treatment assignment for calves that survived ( ) or died ( ) during the 56-d experiment. 
P = 0.008.  
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Figure 3.10. Plasma IgG ( ), plasma total protein by refractometry (TPR, ), and plasma 
total protein by cobas (TPC, ) before treatment assignment. PlasmaTPR measured upon 
arrival was usded to stratify and block the calves; IgG determined by radial immonodifusion and 
TPC were analyzed after the experiment. P > 0.05.  
